β1-Adrenoceptor Arg389Gly Polymorphism and Heart Disease: Marching Toward Clinical Practice Integration
- 1 July 2015
- journal article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 16 (10) , 1035-1038
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolismNature Genetics, 2012
- β1 Adrenergic Receptor Polymorphisms and Heart Failure: A Meta-Analysis on Susceptibility, Response to β-Blocker Therapy and PrognosisPLOS ONE, 2012
- Adrenergic Signaling Polymorphisms and Their Impact on Cardiovascular DiseasePhysiological Reviews, 2010
- Association of β‐1 and β‐2 adrenergic receptor gene polymorphisms with myocardial infarctionJournal of Clinical Laboratory Analysis, 2009
- Real-time optical recording of β1-adrenergic receptor activation reveals supersensitivity of the Arg389 variant to carvedilolJournal of Clinical Investigation, 2007
- A polymorphism within a conserved β1-adrenergic receptor motif alters cardiac function and β-blocker response in human heart failureProceedings of the National Academy of Sciences, 2006
- β1-adrenergic receptor gene polymorphisms in Mexican patients with idiopathic dilated cardiomyopathyExperimental and Molecular Pathology, 2006
- The Arg389Gly Beta1-Adrenoceptor Polymorphism and Catecholamine Effects on Plasma-Renin ActivityJACC, 2005
- Greater inotropic and cyclic AMP responses evoked by noradrenaline through Arg389 β1‐adrenoceptors versus Gly389 β1‐adrenoceptors in isolated human atrial myocardiumBritish Journal of Pharmacology, 2003
- Suppressive Effect of the Gly389 Allele of the .BETA.1-Adrenergic Receptor Gene on the Occurrence of Ventricular Tachycardia in Dilated Cardiomyopathy.Circulation Journal, 2002